| Application | Recommended Dilution |
|---|---|
| IHC | 1:50-1:200 |
SPN, also known as CD43 or leukosialin, is a heavily glycosylated transmembrane sialoglycoprotein expressed predominantly on hematopoietic cells, where it plays essential roles in T cell activation, leukocyte adhesion, and immune cell signaling. As one of the major surface glycoproteins on leukocytes, SPN serves as a valuable marker for studying immune cell populations, lymphocyte biology, and various hematological malignancies, making it a frequent target in both basic immunology research and clinical pathology applications.
This recombinant monoclonal antibody, clone 8E3, offers the reproducibility and consistency that demanding research protocols require. Because recombinant antibodies are produced from defined genetic sequences rather than traditional hybridoma methods, researchers benefit from lot-to-lot uniformity that supports longitudinal studies and ensures experimental results remain comparable across extended projects. The human IgG1 isotype format and affinity-chromatography purification further contribute to reliable performance with minimal background interference.
Validation studies demonstrate robust performance in immunohistochemistry applications on human tissues. Testing in paraffin-embedded human lung and lymph node sections using citrate buffer antigen retrieval at pH 6.0 shows clear specific staining at dilutions ranging from 1:50 to 1:200, giving researchers flexibility to optimize signal intensity for their particular tissue types and detection systems. The antibody has also been validated for ELISA applications, expanding its utility across different experimental workflows.
For investigators studying leukocyte biology, immune cell trafficking, or characterizing lymphoid tissues in health and disease states, this SPN antibody provides a dependable tool backed by documented performance in human tissue applications. Its suitability for immunohistochemistry makes it particularly valuable for researchers examining immune cell infiltration patterns or conducting tissue-based biomarker studies.
Email: support@cusabio.com
Distributors Worldwide